ReviewJournal of clinical medicine2024

New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?

Pau AbrisquetaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.